Document is current
Any future updates will be listed below
-
Authors
Zhang, Yiwen https://orcid.org/0000-0002-1193-2263
Stopsack, Konrad H. https://orcid.org/0000-0002-0722-1311
Wu, Kana
Song, Mingyang https://orcid.org/0000-0002-1324-0316
Mucci, Lorelei A.
Giovannucci, Edward https://orcid.org/0000-0002-6123-0219
-
Funding
Funding for this research was provided by:
Prostate Cancer Foundation
- License Information
-
More Information
Article History
Received: 29 July 2023
Revised: 29 February 2024
Accepted: 4 March 2024
First Online: 15 March 2024
Competing interests
: LAM received research funding from Astra Zeneca and Janssen; was a consultant to Bayer; serves on the SAB and has equity in Convergent Therapeutics. None of these activities were related to the work under review.
: Our study was approved by the institutional review boards of Harvard T.H. Chan School of Public Health, and those of participating registries as required. Completion of the questionnaire was considered to imply informed consent.
